EGFR and non-small cell lung carcinoma: This cohort study describes the largest cohort of early-stage resected EGFR-positive NSCLC contrasted against wildtype EGFR NSCLC with the longest stage-specific survival data and significant representation across stage IA to IIIA to our knowledge.